Literature DB >> 31901402

The clinical and genetic spectrum in infants with (an) unprovoked cluster(s) of focal seizures.

Aalt van Roest1, Anouk Van de Vel1, Damien Lederer2, Berten Ceulemans3.   

Abstract

BACKGROUND: Self-limited (familial) infantile epilepsy (S(F)IE), formerly known as benign (familial) infantile convulsions (B(F)IC), is an infantile cluster epilepsy with in rule a complete recovery. This form of epilepsy is most often caused by variations in the PRRT2 gene (OMIM #605751). AIM: To describe the clinical and genetic spectrum of sudden onset clusters of focal seizures in infancy.
METHODS: We retrospectively reviewed all individuals, who presented with unprovoked infantile seizures and selected all infants who had unprovoked clustered focal seizures between 1 and 20 months of age. We described the clinical and genetic spectrum of this cohort.
RESULTS: The data of 23 patients from 21 families were collected. All had an initial diagnosis of S(F)IE which was adjusted in 5 individuals. In 12 individuals a pathogenic variation in PRRT2 gene or complete deletion was identified. Pathogenic variants in PCDH19 and KCNQ2 were found in respectively 3 and 1 individuals. One individual had a non-pathogenic variant in ATP1A3 and in 6 others no variants were identified. The mean cluster duration was 2.9 days (range 1-13) (see Table 1). Twelve infants had only one cluster. All patients had focal motor or non-motor seizures, in 12 (52%) followed by bilateral (tonic)clonic seizures. Positive family history was present in 74% of individuals. In 11/12 (92%) tested families, ≥1 family member carried the pathogenic PRRT2 variant. Age of seizure onset (ASO) averaged 6.2 months (range 2-20 months). Age of latest seizure averaged 16 months (range 2-92). In several interictal EEG (electroencephalogram) recordings multifocal spikes or spike-wave abnormalities were detected. Ictal EEG recordings detected primary focal abnormalities.
CONCLUSION: We described 23 individuals with unprovoked cluster(s) of focal seizures at infancy. It appears to be a heterogeneous group. Half of them had a pathogenic variation in PRRT2 gene. Most had only one cluster of seizures. When clusters reoccur frequently, when seizures are more therapy-resistant and when seizures persist beyond the age of 2 years, another diagnosis or causative gene is likely.
Copyright © 2020 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clustered seizures; Familial; Focal seizures; Infantile seizures; PRRT2; Self-limited

Mesh:

Substances:

Year:  2019        PMID: 31901402     DOI: 10.1016/j.ejpn.2019.12.003

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  3 in total

1.  Epilepsy surgery in PCDH 19 related developmental and epileptic encephalopathy: A case report.

Authors:  Lakshmi Nagarajan; Soumya Ghosh; Jason Dyke; Sharon Lee; Jonathan Silberstein; Dimitar Azmanov; Warne Richard
Journal:  Epilepsy Behav Rep       Date:  2022-07-06

Review 2.  Recommendations for the diagnosis and treatment of paroxysmal kinesigenic dyskinesia: an expert consensus in China.

Authors:  Li Cao; Xiaojun Huang; Ning Wang; Zhiying Wu; Cheng Zhang; Weihong Gu; Shuyan Cong; Jianhua Ma; Ling Wei; Yanchun Deng; Qi Fang; Qi Niu; Jin Wang; Zhaoxia Wang; You Yin; Jinyong Tian; Shufen Tian; Hongyan Bi; Hong Jiang; Xiaorong Liu; Yang Lü; Meizhen Sun; Jianjun Wu; Erhe Xu; Tao Chen; Tao Chen; Xu Chen; Wei Li; Shujian Li; Qinghua Li; Xiaonan Song; Ying Tang; Ping Yang; Yun Yang; Min Zhang; Xiong Zhang; Yuhu Zhang; Ruxu Zhang; Yi Ouyang; Jintai Yu; Quanzhong Hu; Qing Ke; Yuanrong Yao; Zhe Zhao; Xiuhe Zhao; Guohua Zhao; Furu Liang; Nan Cheng; Jianhong Han; Rong Peng; Shengdi Chen; Beisha Tang
Journal:  Transl Neurodegener       Date:  2021-02-16       Impact factor: 8.014

3.  Characteristics of infantile convulsions and choreoathetosis syndrome caused by PRRT2 mutation.

Authors:  Yaxian Deng; Juanyu Xu; Chunmei Yao; Lei Wang; Xiaohuan Dong; Chengsong Zhao
Journal:  Pediatr Investig       Date:  2022-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.